Related Experiment Video
Updated: Aug 18, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
Signaling intricacies take center stage in cancer cells
1Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. rkumar@mdanderson.org
Abstract:
After many years of productive study on the signaling networks, posttranslational regulatory control of effector molecules remains an intensely investigated and continuously evolving field of research to connect signaling with phenotypic changes. In recent years, there have been intriguing results on the interaction of critical molecules to control the growth of cancer cells. This review article will focus on two critical convergence signaling nodules, Akt and p21-activated kinase, two integral components of phenotypic signaling during tumorigenesis. Here we will summarize the recent findings on how these master signaling nodules regulate their targets and alter the subcellular localization of their effectors to control their functionality. Based on the laboratory advances in the Akt and p21-activated kinase signaling pathways, it is conceivable to start defining novel avenues to develop targeted anticancer therapies.
Insights
This review explores how Akt and p21-activated kinase signaling pathways regulate cancer cell growth. Understanding these critical molecular interactions may lead to new targeted anticancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Posttranslational control of effector molecules is crucial for linking signaling networks to phenotypic changes.
- Recent research highlights molecular interactions that regulate cancer cell growth.
- Akt and p21-activated kinase are key signaling nodes in tumorigenesis.
Purpose of the Study:
- To review recent findings on Akt and p21-activated kinase signaling pathways.
- To summarize how these pathways regulate targets and effector localization.
- To explore potential for novel targeted anticancer therapies.
Main Methods:
- Literature review of recent advances in Akt and p21-activated kinase signaling.
- Analysis of molecular mechanisms regulating effector function and localization.
- Synthesis of current knowledge to identify therapeutic avenues.
Main Results:
- Akt and p21-activated kinase signaling pathways converge to control cancer cell phenotypes.
- Regulation of target molecules and subcellular localization are key functions.
- These pathways offer insights into cancer progression and therapeutic strategies.
Conclusions:
- Akt and p21-activated kinase play critical roles in cancer cell signaling and growth.
- Understanding their regulatory mechanisms is vital for developing targeted therapies.
- Advances in studying these pathways pave the way for novel anticancer drug development.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
What is Cell Signaling?
What is Cell Signaling?
